Wells Fargo’s WebMD Health Corp. WBMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-141,125
Closed -$8.28M 6635
2017
Q2
$8.28M Buy
141,125
+7,944
+6% +$443K ﹤0.01% 2061
2017
Q1
$7.02M Buy
133,181
+9,557
+8% +$488K ﹤0.01% 2169
2016
Q4
$6.13M Buy
123,624
+7,468
+6% +$386K ﹤0.01% 2235
2016
Q3
$5.77M Buy
116,156
+64,754
+126% +$3.57M ﹤0.01% 2175
2016
Q2
$2.99M Buy
51,402
+345
+0.7% +$21.6K ﹤0.01% 2687
2016
Q1
$3.2M Buy
51,057
+18,835
+58% +$1.01M ﹤0.01% 2600
2015
Q4
$1.56M Buy
32,222
+4,379
+16% +$195K ﹤0.01% 3176
2015
Q3
$1.11M Sell
27,843
-2,297
-8% -$97.1K ﹤0.01% 3422
2015
Q2
$1.33M Buy
30,140
+8,174
+37% +$373K ﹤0.01% 3387
2015
Q1
$963K Buy
21,966
+3,098
+16% +$129K ﹤0.01% 3564
2014
Q4
$746K Sell
18,868
-7,518
-28% -$289K ﹤0.01% 3698
2014
Q3
$1.1M Buy
26,386
+23,248
+741% +$1.12M ﹤0.01% 3413
2014
Q2
$151K Buy
3,138
+515
+20% +$22.5K ﹤0.01% 4509
2014
Q1
$109K Buy
2,623
+1,044
+66% +$47K ﹤0.01% 4620
2013
Q4
$62K Buy
1,579
+575
+57% +$20.7K ﹤0.01% 4680
2013
Q3
$28K Sell
1,004
-442,015
-100% -$13.8M ﹤0.01% 4865
2013
Q2
$13M Buy
+443,019
New +$11.8M 0.01% 1407

Other funds holding WBMD

Wells Fargo's WBMD Position: Q3 2017 in Review

Wells Fargo sold out of WebMD Health Corp. (WBMD) in Q3 2017, closing a stake of 141,125 shares — an estimated $8.28M sold.

Wells Fargo first reported a position in WBMD in Q2 2013 and held it in 17 quarters. The position peaked at $13M in Q2 2013. 1 fund tracked by Wall St. Rank holds WBMD as of Q3 2017.

  • Wells Fargo reported no remaining WebMD Health Corp. position as of Q3 2017 after selling out during the quarter.
  • Wells Fargo sold 141,125 WebMD Health Corp. shares in Q3 2017, an estimated $8.28M.
  • Wells Fargo first reported a position in WebMD Health Corp. in Q2 2013 and held it in 17 quarters.
  • Wells Fargo's WebMD Health Corp. position peaked at $13M in Q2 2013.
  • 1 fund tracked by Wall St. Rank held WebMD Health Corp. as of Q3 2017.

Based on Wells Fargo's 13F filing for Q3 2017, filed 9 Nov 2017.